• UK commits the equivalent of £330 million per year to Gavi, the Vaccine Alliance for the 2021-25 five-year period
  • Funding will support Gavi’s efforts to vaccinate 300 million children across the developing world, saving up to 8 million lives
  • Pledge will also support Gavi’s response to COVID-19 across Africa and Asia, as well as Gavi’s efforts to ensure the poorest countries recover from the impact of the COVID-19 pandemic on routine immunisation as we prepare for the availability of a COVID-19 vaccine

Geneva, 29 April 2020 – Gavi, the Vaccine Alliance has welcomed a pledge equivalent to £330 million per year for Gavi’s 2021-25 period announced today by Anne-Marie Trevelyan, Secretary of State for the UK Department for International Development (DFID).

The UK has been Gavi’s largest donor since its inception in 2000, playing a leading role in immunising a whole generation – over 760 million children – and helping to halve child mortality in 73 developing countries over the past two decades. The UK has also been a leading contributor to all Gavi’s innovative finance mechanisms, including the International Finance Facility for Immunisation. The UK pledge follows commitments from Germany and the Bill & Melinda Gates Foundation, USA, Saudi Arabia, TikTok, Reed Hastings & Patty Quillin, and Alwaleed Philanthropies.

“Gavi’s work has never been more important,” said Dr Ngozi Okonjo-Iweala, Chair of the Gavi Board. “Right now it is playing a vital role both keeping immunisation programmes going across the world, reducing the chances of there being further global disease outbreaks, as well as helping developing countries respond to the COVID-19 pandemic. As long as there are still pockets of this disease somewhere, everywhere is at risk. This pledge will make a huge difference to these efforts and I’d like to thank the UK, as Gavi’s biggest donor since its inception, for their leadership over the past two decades.”

“I’d like to thank the UK public for this pledge: an investment in Gavi is an investment in a safer, healthier world,” said Dr Seth Berkley, CEO of Gavi. “This funding will not only protect hundreds of millions of children against disease, it will also help health systems to repair and rebuild after the enormous impact of COVID-19 has subsided. This is our best shield against future pandemics which, as we have seen all too clearly in recent months, do not respect borders. Finally, it means we can continue our work leading international efforts to ensure universal access to a COVID-19 vaccine, as well as to maintain the infrastructure needed to deploy it at scale around the world, which offers our best means of ending this crisis.”

As well as pledging to Gavi’s 2021-25 period, the UK government will also host the Global Vaccine Summit on 4 June, which aims to raise a total of at least US$ 7.4 billion to support Gavi’s work over the next five years.

At Gavi’s last pledging conference, in Berlin in 2015, UK committed £1 billion (US$1.38 billion) to Gavi’s 2016-20 five-year period.


COVID-19 related

How long after I get COVID-19 will I test negative?

Testing positive for COVID-19 – even without symptoms – can be disruptive to daily life, but how long should we expect to test positive for?

First published on 29 October 2021, updated on 13 September 2022

Call for Applications: COVAX seeks experts for independent group on evidence-based vaccine decision-making

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and…

Q&A: Science ‘needs to listen to African voices’

Public speaking a lifelong skill for scientists. Drive behind research should come from grassroots. Science and art merge together in field of communication.

How did Kenya surpass its 2021 COVID-19 vaccination target?

Kenya was aiming to reach 10 million people with COVID-19 vaccines by the end of December 2021. Thanks to a clear strategy, COVAX support and the hard work of thousands of health workers, they reached their target.

Could mRNA vaccines protect against HIV?

Moderna has begun a trial with an experimental HIV vaccine based on the same technology underpinning its COVID-19 vaccine.

What’s the best way to tackle COVID and climate change? Anthropology, says the woman who predicted the global financial crisis

Financial Times journalist and author Gillian Tett discusses her new book, Anthro-Vision: How Anthropology Can Explain Business and Life.

The Equity Agenda in Fourth Industrial Revolution Healthcare Technology

The COVID-19 pandemic has demonstrated the power of innovative Fourth Industrial Revolution (4IR) technologies in healthcare systems. Unless these technologies are designed with equity at their core, we risk leaving some people even further…

Subscribe to our newsletter